These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28017537)

  • 1. Human leukocyte antigen and idiosyncratic adverse drug reactions.
    Usui T; Naisbitt DJ
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):21-30. PubMed ID: 28017537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Association with Drug-Induced Adverse Reactions.
    Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
    J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhou P; Zhang S; Wang Y; Yang C; Huang J
    J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions.
    Ramsbottom KA; Carr DF; Jones AR; Rigden DJ
    Mol Immunol; 2018 Sep; 101():488-499. PubMed ID: 30125869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of allopurinol--making an old drug safer.
    Lam MP; Yeung CK; Cheung BM
    J Clin Pharmacol; 2013 Jul; 53(7):675-9. PubMed ID: 23381951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions].
    Aoki S
    Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls.
    Daly AK
    Curr Drug Metab; 2014 Feb; 15(2):196-201. PubMed ID: 24694233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in study on the association between HLA genetic variation and adverse drug reactions.
    Liu Y; Zeng X; Ouyang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):404-413. PubMed ID: 33967088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive genomic markers for severe adverse drug reactions].
    Saito Y; Kodama S; Sugiyama E; Nakamura R
    Yakugaku Zasshi; 2015; 135(4):589-95. PubMed ID: 25832839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune pathomechanism of drug hypersensitivity reactions.
    Pichler WJ; Naisbitt DJ; Park BK
    J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
    Yip VL; Alfirevic A; Pirmohamed M
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):165-75. PubMed ID: 24777842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine.
    Hung SI; Chung WH; Chen YT
    Per Med; 2005 Aug; 2(3):225-237. PubMed ID: 29793265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.